Balyasny Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
245,624
+74,241
| +43% | +$685K | ﹤0.01% | 1130 |
|
|
2025
Q1 | $1.47M | Buy |
+171,383
| New | +$1.47M | ﹤0.01% | 1242 |
|
|
2024
Q3 | – | Sell |
-24,349
| Closed | -$103K | – | 1953 |
|
|
2024
Q2 | $103K | Sell |
24,349
-58,731
| -71% | -$248K | ﹤0.01% | 1765 |
|
|
2024
Q1 | $423K | Buy |
83,080
+13,779
| +20% | +$70.1K | ﹤0.01% | 1532 |
|
|
2023
Q4 | $645K | Buy |
69,301
+44,030
| +174% | +$410K | ﹤0.01% | 1330 |
|
|
2023
Q3 | $166K | Sell |
25,271
-18,882
| -43% | -$124K | ﹤0.01% | 1579 |
|
|
2023
Q2 | $359K | Buy |
44,153
+13,878
| +46% | +$113K | ﹤0.01% | 1550 |
|
|
2023
Q1 | $259K | Sell |
30,275
-28,706
| -49% | -$246K | ﹤0.01% | 1734 |
|
|
2022
Q4 | $546K | Buy |
58,981
+1,884
| +3% | +$17.4K | ﹤0.01% | 1414 |
|
|
2022
Q3 | $589K | Buy |
+57,097
| New | +$589K | ﹤0.01% | 1538 |
|
|
2017
Q4 | – | Sell |
-14,616
| Closed | -$61K | – | 1799 |
|
|
2017
Q3 | $61K | Buy |
+14,616
| New | +$61K | ﹤0.01% | 1599 |
|
|
2016
Q2 | – | Sell |
-20,050
| Closed | -$98K | – | 981 |
|
|
2016
Q1 | $98K | Buy |
+20,050
| New | +$98K | ﹤0.01% | 998 |
|